Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

autoimmune disease, developmental biology, ecology, immunology
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
Katarina Zimmer | May 26, 2020
There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
Abby Olena | May 21, 2020
The viral protein known as ORF3b limits the induction of the type I interferon response, which typically alerts other immune system components to the presence of a virus, in cultured cells.
Losing Touch: Another Drawback of the COVID-19 Pandemic
Losing Touch: Another Drawback of the COVID-19 Pandemic
Ashley Yeager | May 19, 2020
Affectionate touches tap into the nervous system’s rest and digest mode, reducing the release of stress hormones, bolstering the immune system, and stimulating brainwaves linked with relaxation.
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Ashley Yeager | May 18, 2020
A clinical trial of the shot in eight volunteers suggests that it is safe and that it generates antibodies that neutralize SARS-CoV-2, but further testing is needed, scientists say.
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Ashley Yeager | May 12, 2020
Data from a crowdsourcing smartphone app is helping to track the spread of the disease in real time and reveals the symptom as the number one indicator of infection.
special report
Why the Accuracy of SARS-CoV-2 Antibody Tests Varies So Much
Why the Accuracy of SARS-CoV-2 Antibody Tests Varies So Much
Diana Kwon | May 5, 2020
The FDA cracks down on test makers as independent evaluations of their products’ performance show a need for improvement.
An Old TB Vaccine Finds New Life in Coronavirus Trials
An Old TB Vaccine Finds New Life in Coronavirus Trials
Anthony King | May 4, 2020
Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19.
Researchers Try to Head Off “Murder Hornets” Coming into US
Researchers Try to Head Off “Murder Hornets” Coming into US
Shawna Williams | May 4, 2020
Asian giant hornets were found for the first time in Washington State and could reemerge in the spring.